Christine Favre‐Guilmard

Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models

Christine Favre‐Guilmard, Michel Auguet, Pierre‐Etienne Chabrier · European Journal of Pharmacology · 2009 · 115 citations

Pain Syndrome, Allergy, Acute Pain +9

Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models

Mark Elliott, Christine Favre‐Guilmard, Sai Liu et al. · Science Advances · 2019 · 41 citations · Full text

A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo

Sarah Donald, Mark Elliott, Bryony Gray et al. · Pharmacology Research & Perspectives · 2018 · 27 citations · Full text

Recombinant botulinum neurotoxin serotype A1 in vivo characterization

Cindy Périer, Vincent Martin, Sylvie Cornet et al. · Pharmacology Research & Perspectives · 2021 · 19 citations · Full text

The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine

Christine Favre‐Guilmard, Hamida Zeroual-Hider, C. Soulard et al. · European Journal of Pharmacology · 2008 · 16 citations

Novel Inhibitor, Biochemistry, Functional Selectivity +13